	GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage. J Eur Acad Dermatol Venereol Hill MA, Treichel A, Cooper KD. PMID: 42627149 [PubMed - as supplied by publisher]
	Lifestyle interventions targeting adiposity in adults with psoriasis: a systematic review and network meta-analysis. Front Nutr Huo R, Li W, Luo H, Su N, Wang T, Gou H, Zhou S. PMID: 42626564 [PubMed]
	Psoriasis as a spatial immune ecosystem: insights from single-cell and spatial transcriptomics. Front Immunol Cheng W, Luo T, Zhou X, Jing H. PMID: 42625987 [PubMed - indexed for MEDLINE]
	Interstitial Lung Disease Induced by Monoclonal Antibodies for Psoriatic Arthritis, a Double Hit: A Case Report with a Literature and Clinical Trial Review. Pulm Ther Castelli G, Fiorentù G, Maggioni G, Bellani S, Giulianelli G, Bernardinello N, Cocconcelli E, Pezzuto F, Polverosi R, Calabrese F, Spagnolo P, Balestro E. PMID: 42622989 [PubMed - as supplied by publisher]
	Corrigendum: Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis. Acta Derm Venereol Maul JT. PMID: 42621680 [PubMed - indexed for MEDLINE]
	CLDN8 and ABCA12 define a shared molecular signature in ulcerative colitis-psoriasis comorbidity. Front Immunol Wang H, Jin K, Zhao Y, Ruan Y, Zhu H, Zhu N. PMID: 42620717 [PubMed - indexed for MEDLINE]
	Prevalence and clinical relevance of anti-drug antibodies in psoriatic arthritis: a systematic review. RMD Open Kimpton J, Akpabio A, Watts A, Tansley S, Smith T, McHugh N, Tillett W. PMID: 42618212 [PubMed - indexed for MEDLINE]
	The Effects of Tildrakizumab in the Epigenetic Aging Deviation of Psoriasis: A 52-Week Open-Label Study. J Am Acad Dermatol Macit B, Benca-Bachman CE, Qureshi A, Paulo de Lima Camillo L, Cho E, McGeary JE, Wambier CG. PMID: 42617697 [PubMed - as supplied by publisher]
	Efficacy and safety of golimumab biosimilar BAT2506 in patients with active psoriatic arthritis after switching from reference golimumab: 52-week results of a phase 3, double-blind, randomized study. Expert Opin Biol Ther Tang H, Dokoupilova E, Batko B, Zawadzki M, Batalov A, Liu Y, Yang X, Zhou Y, Dong Q, Liu Y. PMID: 42615128 [PubMed - as supplied by publisher]
	Qingre Liangxue Acupuncture for Psoriasis: A Cholinergic Neuroimmune Framework. Int J Gen Med Liu L, Liu W, Liu RJ. PMID: 42614788 [PubMed]
	Resolution of systemic inflammation in psoriasis following herring roe oil treatment: a post hoc analysis on inflammatory biomarkers in non-severe psoriatic patients. Front Med (Lausanne) Ringheim-Bakka TA, Gammelsaeter R, Tveit KS. PMID: 42614141 [PubMed]
	Inhibition of Salt-Inducible Kinases 2 and 3 reduces inflammatory signature in Psoriasis. J Invest Dermatol Pilz AC, Briem E, Colli M, Hillig C, Lavazais S, Menden MP, Biedermann T, Lauffer F, Eyerich K, De Vos S, Jargosch M. PMID: 42612789 [PubMed - as supplied by publisher]
	Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial. Am J Clin Dermatol Han L, Qin H, Lu X, Zhang L, Li L, Han H, Wang J, Duan X, Sun D, Yang W, Ren H, Wang X, Ci C, Wang Y, Han X, Yin W, Yu C, Zhang M, Zhu J, Wu L, Meng Z, Zeng T, Wang H, Shan Y, Ding Y, Feng W, Zhang X, Zhang G, Guo Q, Cheng H, Ji C, Fang R, Dong X, Zhu X, Lei T, Yang X, Xiao R, Liu Z, Tao X, Chen R, Lou J, Liu Y, Zhang J, Xu J. PMID: 42611163 [PubMed - as supplied by publisher]
	Clinical field tests to evaluate cardiorespiratory fitness in psoriatic arthritis. Arthritis Care Res (Hoboken) Kaerts M, De Vlam K, Lories R, Swinnen TW, Neerinckx B. PMID: 42605826 [PubMed - as supplied by publisher]
	Effectiveness and Safety of Spesolimab in Adolescents and Adults with Generalized Pustular Psoriasis. Pragmat Obs Res Li CT, Guo JZ, Zhou YT, Su J, Wang WH. PMID: 42604245 [PubMed]
	Reply to: "Interpreting infection-disease associations in psoriasis and atopic dermatitis". JAAD Int Zhou Z, Xiao Y. PMID: 42602945 [PubMed]
	Discriminative performance of non-invasive scoring systems for VCTE-defined steatosis and fibrosis in patients with psoriasis. Hepatol Forum Yuksel S, Ergun T, Ozdogan OC, Alahdab YO, Yilmaz V, Atmaca G, Kara U, Demirtas CO. PMID: 42602073 [PubMed]
	Trajectory-based profiling of 52-week secukinumab response reveals baseline clinical and transcriptomic differences in plaque psoriasis. Front Immunol Wang X, Han L, Li J, Rao Y, Zhang S, Yu N. PMID: 42601936 [PubMed - indexed for MEDLINE]
	Factors associated with interferon-gamma release assay positivity in patients with psoriasis: a cross-sectional study. BMC Infect Dis Song H, Zhang Y, Zhang Q, Zhang J, Gu W, Yang P, Xiao Y, Liu F, Li M, Ding W, Song K, Qiao L, Li Y, Ma Y. PMID: 42601602 [PubMed - indexed for MEDLINE]
	Association Between Efficacy and Pharmacokinetics of DMB-3115 and its Originator Ustekinumab in Patients with Chronic Plaque Psoriasis: An Exposure-Response Analysis. Adv Ther Konishi H, Shindo T, Ishiwata K, Morita J. PMID: 42599580 [PubMed - as supplied by publisher]

Articles 1 - 20 / 28421

Page 1 of 1422



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy